http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#Head http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ http://www.nanopub.org/nschema#hasAssertion http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#assertion http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ http://www.nanopub.org/nschema#hasProvenance http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#provenance http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ http://www.nanopub.org/nschema#hasPublicationInfo http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#pubinfo http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#assertion http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#_1 http://purl.obolibrary.org/obo/RO_0002204 http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=1100 http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080 http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://disease-ontology.org/term/DOID:1612 http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606 http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-diseases/Cisplatin%20resistance http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://www.selventa.com/vocabulary/increases http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#_1 http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#assertion http://www.w3.org/2000/01/rdf-schema#label p(HGNC:BRCA1) -> path(SDIS:"Cisplatin resistance") http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#provenance http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/description Approximately 61,000 statements. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/rights Copyright (c) 2011-2012, Selventa. All rights reserved. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/title BEL Framework Large Corpus Document http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/authoredBy http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#_4 http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/version 20131211 http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#_3 http://www.w3.org/ns/prov#value Two Rz, targeting positions 358 or 5282 of the BRCA1 mRNA, were cloned into the retroviral vector LXSN and lipofected into the breast cancer cell-line HBL100. We obtained 79-99% inhibition of BRCA1 expression, as determined by real-time quantitative PCR and by Western blotting. Decreased expression of BRCA1 led to sensitivity to the DNA damaging agents cisplatin and etoposide, resistance to the microtubule-interfering agents (MIA) taxol and vincristine. T http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#_3 http://www.w3.org/ns/prov#wasQuotedFrom http://www.ncbi.nlm.nih.gov/pubmed/11641785 http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#_4 http://www.w3.org/2000/01/rdf-schema#label Selventa http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#assertion http://www.w3.org/ns/prov#hadPrimarySource http://www.ncbi.nlm.nih.gov/pubmed/11641785 http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#_3 http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ#pubinfo http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ http://purl.org/dc/terms/created 2014-07-03T14:31:44.270+02:00 http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ http://purl.org/pav/createdBy http://orcid.org/0000-0001-6818-334X http://www.tkuhn.ch/bel2nanopub/RAG2tl2xIGb15kX4_4ib1LAmTF1y5Go8pwsR3uyzn53xQ http://purl.org/pav/createdBy http://orcid.org/0000-0002-1267-0234